Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series - 15/04/20
Doi : 10.1016/j.jaad.2020.02.050
Christina Wong, MD a, ⁎ 
, Christine Poblete-Lopez, MD b, Allison Vidimos, RPh, MD b
, Christine Poblete-Lopez, MD b, Allison Vidimos, RPh, MD b a Department of Dermatology, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio
b Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio
∗Correspondence to: Christina Wong, MD, Case Western Reserve University, University Hospitals Cleveland Medical Center, Two Chagrin Highlands, 3000 Auburn Dr, Ste 125, Beachwood OH 44122Case Western Reserve UniversityUniversity Hospitals Cleveland Medical CenterTwo Chagrin Highlands3000 Auburn DrSte 125BeachwoodOH44122
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Wednesday 15 April 2020
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?